(Total Views: 376)
Posted On: 10/28/2020 12:25:47 PM
Post# of 36509
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Posted by Generex on LinkedIn 23 minutes ago
While people exposed to #SARSCoV2 have been shown to acquire #immunity to the coronavirus for a few months, our Ii-key #vaccine aims to immunize against SARS-CoV-2 over a longer period by inducing long-term T-cell memory responses.
#sarscov2 #covid19 #immunology #immunotherapy #immunooncology #tcells #biotechnology #coronavirus #Iikeypeptide
While people exposed to #SARSCoV2 have been shown to acquire #immunity to the coronavirus for a few months, our Ii-key #vaccine aims to immunize against SARS-CoV-2 over a longer period by inducing long-term T-cell memory responses.
#sarscov2 #covid19 #immunology #immunotherapy #immunooncology #tcells #biotechnology #coronavirus #Iikeypeptide
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)